Cargando…
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide implementation of preventive measures to combat the disease. Although most COVID‐19 cases are characterised by a mild, self‐limiting disease...
Autores principales: | van Eijk, Larissa E, Binkhorst, Mathijs, Bourgonje, Arno R, Offringa, Annette K, Mulder, Douwe J, Bos, Eelke M, Kolundzic, Nikola, Abdulle, Amaal E, van der Voort, Peter HJ, Olde Rikkert, Marcel GM, van der Hoeven, Johannes G, den Dunnen, Wilfred FA, Hillebrands, Jan‐Luuk, van Goor, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013908/ https://www.ncbi.nlm.nih.gov/pubmed/33586189 http://dx.doi.org/10.1002/path.5642 |
Ejemplares similares
-
Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
por: Bourgonje, Arno R, et al.
Publicado: (2020) -
Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis
por: Abdulle, Amaal Eman, et al.
Publicado: (2018) -
Correction: Abdulle, A.E., et al. Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis. Int. J. Mol. Sci. 2018, 19, 4121
por: Abdulle, Amaal Eman, et al.
Publicado: (2019) -
Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study
por: van Eijk, Larissa E., et al.
Publicado: (2021) -
The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
por: Abdulle, Amaal E., et al.
Publicado: (2018)